The invention relates to the field of animal health. In particular, the invention relates to an oral solid dosage form comprising, as pharmaceutically active compounds, amlodipine. The invention relates to an oral solid dosage forms comprising an amlodipine besylate according to a particular posology for the treatment of hypertension in non-human mammal animals.